RSS Items

Drugmaker has benefited from its bet on developing a portfolio of cancer drugs

FTSE 100 group reportedly faces difficulties in selling drugs to Chinese hospitals

Gracell Biotechnologies would operate as wholly owned subsidiary under terms of deal

Almost 36 per cent of shareholders voted against a £1.8mn rise for the pharma group’s boss

Shareholder advisory groups say potential £18.7mn payout is excessive

Investigation of group’s China chief Leon Wang continues after several employees were found guilty of fraud

Anglo-Swedish drugmaker’s oncology and rare disease medication sales offset waning demand for Covid jabs

Anglo-Swedish drugmaker’s oncology and rare disease medication sales offset waning demand for Covid-19 jabs

UK pharma group agrees to buy Seattle-based biotech Icosavax

Deal with Absci is the latest between big pharma and tech companies to build new disease treatments